Trinity Biotech (TRIB) received notice from Nasdaq that the company no longer meets the requirement in Nasdaq Listing Rule 5450 that listed securities maintain a minimum market value of publicly held shares of $15M, based on Nasdaq’s review of the company’s MVPHS for the last 30 consecutive business days.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech Faces Nasdaq Bid-Price Deficiency, Given Until August to Regain Compliance
- Trinity Biotech receives noncompliance notification from Nasdaq
- Trinity Biotech’s Premier Hb9210 Wins Sole IFCC Gold HbA1c Classification for 2026
- Trinity secures regulatory approval for upstream manufacturing activities
- Trinity achieves IFCC Gold Classification for Premier Hb9210 HbA1c Analyser